Sorrento Therapeutics to Participate in Morgan Stanley 20th Annual Global Healthcare Conference September 12-14

On September 8, 2022 Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") reported that Henry Ji, Ph.D., Chairman, President and Chief Executive Officer, and members of Sorrento’s executive team will participate the 20th Annual Morgan Stanley Global Healthcare Conference (Press release, Sorrento Therapeutics, SEP 8, 2022, View Source [SID1234619266]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 20th Annual Global Healthcare Conference

Location: New York City
Dates: September 12 – 14, 2022
Company Presentation: September 14, 2022, at 8:00 am Eastern time
CEO Fireside Chat Format and Available for 1×1 Investor Meetings